List of Treatments for Autoimmune Hemolytic Anemia

Azathioprine

Overview
Azathioprine is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to help prevent rejection after a kidney transplant. It is sometimes used off-label to treat symptoms of… read more

Bortezomib

Overview
Bortezomib is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat mantle cell lymphoma and multiple myeloma. Bortezomib is sometimes prescribed off-label to treat… read more

Corticosteroids

Overview
Corticosteroids are a class of prescription drugs approved by the U.S. Food and Drug Administration (FDA) to treat the body’s inflammatory and metabolic response. Corticosteroids are often used off-label as a… read more

Cyclophosphamide

Overview
Cyclophosphamide is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating cancers including multiple myeloma, leukemia, and lymphoma. In some cases, cyclophosphamide is… read more

Cyclosporine

Overview
Cyclosporine is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to prevent the rejection of transplanted organs. Cyclosporine is also used off-label to treat autoimmune hemolytic… read more

Enjaymo (Sutimlimab-jome)

Overview
Enjaymo is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2022 to treat cold agglutinin disease (CAD), a type of autoimmune hemolytic anemia (AIHA). Enjaymo is also known by its… read more

Erythropoietin-Stimulating Agents

Overview
Erythropoietin-stimulating agents (ESAs) simulate erythropoietin, a hormone that stimulates red blood cell production in the bone marrow. Erythropoietin is secreted by the kidneys.

There are two ESAs… read more

Mycophenolate mofetil

Overview
Mycophenolate mofetil is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to prevent rejection in organ transplant recipients. Mycophenolate mofetil is sometimes prescribed off-label… read more